ArticleFrontiers in cellular neuroscience2025
Establishment of an AI-supported scoring system for neuroglial cells.
Article in Frontiers in cellular neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Microglial TREM2 and cognitive impairment: insights from Alzheimer's disease with implications for spinal cord injury and AI-assisted therapeutics.Frontiers in cellular neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The feasibility of a computer-aided scoring system based on artificial intelligence to detect and classify morphological changes in neuroglial cells was assessed in this study. The system was applied to hippocampal organotypic slice cultures (OHC) from 5 to 7 day-old wild-type and TNF-overexpressing mice in order to analyze effects of a proinflammtory stimulus such as TNF. The area fraction of cells, cell number, number of cell processes and area of the cell nucleus were used as target variables. Immunfluorescence labeling was used to visualize neuronal processes (anti-neurofilaments), microglia (anti-Iba1) and astrocytes (anti-GFAP). The analytic system was able to reliably detect differences in the applied target variables such as the increase in neuronal processes over a period of 14 days in both mouse lines. The number of microglial projections and the microglial cell number provided reliable information about activation level. In addition, the area of microglial cell nuclei was suitable for classification of microglia into activity levels. This scoring system was supported by description of morphology, using the automatically created cell masks. Therefore, this scoring system is suitable for morphological description and linking the morphology with the respective cellular activity level employing analyses of large data sets in a short time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.